Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive therapy in resistant epilepsy.

N Callaghan1, T Goggin

  • 1Dept. of Neurology, Cork Regional Hospital, Ireland.

Epilepsia
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prototype differential atom interferometer for fundamental physics.

Nature·2026
Same author

Overriding water table control on managed peatland greenhouse gas emissions.

Nature·2021
Same author

Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an <i>In Vitro</i> Wound Model.

Antimicrobial agents and chemotherapy·2021
Same author

Effects and side effects of maternal administration of indomethacin for fetal tricuspid valve dysplasia.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Dissolved organic nutrient uptake by riverine phytoplankton varies along a gradient of nutrient enrichment.

The Science of the total environment·2020
Same author

Serial levels of plasma linoleic acid in tetanus.

Irish journal of medical science·2016
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

For epilepsy patients not responding to initial monotherapy, add-on drug treatments can improve seizure control. While complete remission is rare, over 40% may experience significant seizure reduction with adjunctive epilepsy medications.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Epilepsy prognosis is generally good with monotherapy, achieving remission in over 75% of patients.
  • Patients refractory to monotherapy or unsuitable for surgery require alternative treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of adjunctive drug regimens in epilepsy patients with persistent seizures.
  • To explore potential indications for additive treatment in managing refractory epilepsy.

Main Methods:

  • Literature review on adjunctive epilepsy treatments.
  • Clinical study assessing clobazam as add-on therapy.
  • Analysis of primidone and valproate as adjunctive treatments in patients refractory to carbamazepine monotherapy.

Main Results:

Related Experiment Videos

  • Adjunctive treatment rarely achieves complete seizure control but can improve seizure control in up to 40% of patients.
  • Clobazam showed initial response in 60% of patients, with 33% maintaining improvement for 18 months.
  • In carbamazepine-refractory patients, primidone or valproate resulted in a >50% seizure reduction in 45% of cases.

Conclusions:

  • Adjunctive pharmacotherapy offers a viable option for improving seizure control in a significant portion of epilepsy patients.
  • Further investigation into specific indications for additive treatments in epilepsy management is warranted.